Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Cognitive Impairment in TBI
NCT02015949Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Feb 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate hydrochloride extended-release chewable tablet in traumatic brain injury (TBI), sponsored by Imperial College London. Started Feb 2014; status: completed.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02015949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015949.